Recent submissions

Comment · 4 days ago
This one took a turn but point taken. You see similar arguments for a great many ailments (sperm count and carpets comes to mind). You can’t well run randomized control trials on every plastic, additive, or manufacturing process. It feels futile to even start.
Comment · 5 days ago
Legendary commentary track
Comment · 2 months ago
They have this already. Both cmux and supacode use libghostty in the backend.
Comment · 3 months ago
It depends on the subject. For classes/subjects that are very terminology-heavy, with a lot of dependencies between topics, memorizing things is a pre-requisite to the "deeper" understanding, especially under time-constraint of a semester or whatever. I think most people would agree that it's ideal to "naturally" explore a subject in order to get a deeper understanding of it, but one can't always be expected to 1. Be able to deploy that "curiosity" for all subjects at any time and 2. Be able to adequately achieve competence in a subject within the given timeframe
Comment · 4 months ago
Codex was running a 2x usage promotion from around the time when Claude introduced rate limiting during peak hours, until May 31st. The various relevant subreddits were (more) insufferable: just 1000 posts per day to the tune of "Just switched the codex! So much more usage!" only to have that tone flip immediately after the promo ran out.
Comment · 4 months ago
Comment · 4 months ago
Craig mentioned near the end of the keynote that compute intensive things (like image generation) will have rate limits that can be increased bundled with their iCloud + plans. I imagine any request that gets routed to their cloud compute will be subject to limits as well. He positioned it as a value-add to their existing subscription but I suppose that can change.
Comment · 2 years ago
There are also downstream consequences of ordering tests aside from cost; not all tests are harmless. As an example, regular screening for prostate cancer isn't recommended as much. Partially because it is often so slow-growing that people often die of other causes before the cancer even begins to cancer, and because the definitive test is a biopsy which is somewhat invasive. Rates of complications are relatively low, but it becomes a cost-benefit consideration (again, irrespective of cost) of if those risks are worth catching something that you may not even want to bother treating.

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton